Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 112405
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.112405
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.112405
Figure 4 The extent of AP-induced intestinal injury was found to be positively correlated with Dachengqitang in mice.
A-C: Hematoxylin and eosin staining showed milder injury in mice treated with Dachengqitang (DCQT); D-I: Immunofluorescence analysis revealed a significant decrease in the intestinal injury marker following 24 hours of AP treatment; J and K: Furthermore, the protein expression of occludin and ZO-1 notably increased post-DCQT treatment, as illustrated in the immunofluorescence images. aP < 0.05. A-I features a scale bar of 50 μm. DCQT: Dachengqitang.
- Citation: Zheng L, Wang J, Xu MQ, Jiang W, Qian L, Ge Y, Feng MK, Zhu YM, Wang MJ, Sun SS, Liu CK, Wang XM, Zhang C. Dachengqitang mitigates endoscopic retrograde cholangiopancreatography-induced pancreatitis. World J Gastrointest Surg 2026; 18(3): 112405
- URL: https://www.wjgnet.com/1948-9366/full/v18/i3/112405.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i3.112405